Oosthuizen Johannes Jacobus 4
4 · Merck & Co., Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Oosthuizen Johannes Jacobus
EVP, Oncology & Int?l
Transactions
- Award
Common Stock
[F1][F2]2025-01-27$97.94/sh+8,664$848,552→ 32,607.474 total
Footnotes (2)
- [F1]Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/22. Performance shares were paid out at 169 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2024.
- [F2]Holdings include shares acquired in dividend reinvestment transactions.
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen|2025-01-29